Identification of ZG16B as a prognostic biomarker in breast cancer
Zymogen granule protein 16B (ZG16B) has been identified in various cancers, while so far the association between ZG16B and breast cancer hasn’t been explored. Our aim is to confirm whether it can serve as a prognostic biomarker in breast cancer. In this study, Oncomine, Cancer Cell Line Encyclopedia...
Guardado en:
Autores principales: | Lu Haotian, Shi Chunying, Liu Xinyu, Liang Chen, Yang Chaochao, Wan Xueqi, Li Ling, Liu Ying |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ceba720823be4fbbb10686e4ea205a41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer
por: Sun Lin, et al.
Publicado: (2021) -
Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer
por: Liu F, et al.
Publicado: (2021) -
Avtonom differensial tenglamalarning qo’zg’almas nuqtalari tasnifi haqida
por: Alijon Xayrulloevich Avezov, et al.
Publicado: (2021) -
Prognostic significance of TRIM28 expression in patients with breast carcinoma
por: Zhang Wen, et al.
Publicado: (2021) -
Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer
por: Gangga Anuraga, et al.
Publicado: (2021)